Wayne State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wayne State University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Wayne State University: 163 sponsored US clinical trials, 22 recruiting.
Wayne State University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 115 completed. 13 of these trials are in Phase 3-4 (later-stage) and 30 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 4 trials.
Top-decile sponsor footprint
Wayne State University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
115 of 125 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 3 of 4
Development of a Couple-based Mindfulness Intervention for Chronic Pain
NCT02316288
Home-Based Interventions for Adolescents With Type 1 Diabetes
NCT02243072
Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder
NCT02069366
Tryptophan Metabolism in Human Brain Tumors-Novocure
NCT02367482
Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms
NCT02151500
Developing a Preschool Obesity Intervention for Families Enrolled in WIC
NCT02292602
Tryptophan Metabolism in Human Brain Tumors
NCT02367469
Achieving Blood Pressure Control Through Enhanced Discharge
NCT02069015
Exercise Behavior Among Young Adults Study
NCT02204176
Stress Management for Irritable Bowel Syndrome
NCT01886027
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES)
NCT01873963
Evaluation of Neuroinflammation in Children With Infantile Spasms
NCT02092883
Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients
NCT01741012
Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse
NCT01959217
Detroit Area Study of College Student Lifestyles
NCT01757353
Indirect Assessment and Intervention for Perinatal Drug Use
NCT01650675
Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth
NCT01594606
Medical Marijuana Use in HIV+ Patients: Probability Survey
NCT01536912
Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
NCT02582203
Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
NCT01536899
Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist
NCT01836055
Rosuvastatin in African Americans With Cerebrovascular Disease
NCT01975194
Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects
NCT01536925
Fondaparinux in Critically Ill Patients With Renal Failure
NCT01467583
Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients
NCT01360476
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)
NCT01392092
Pain and Stress Management for Fibromyalgia
NCT01287481
Computerized Intervention of Parental Involvement in Diabetes Care of Their Child
NCT01515930
Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy
NCT01643044
Text Messaging to Improve Hypertension Medication Adherence in African Americans
NCT01465217
Stress Reduction in Middle Eastern Refugees
NCT01288690
Effect of Group Pilates and Yoga Exercise Classes for Chronic Cervical Pain
NCT01999283
Safety and Feasibility of Minocycline in the Treatment of Traumatic Brain Injury (TBI)
NCT01058395
Stress Management for Chronic Headaches
NCT00956969
Comparison of the Effectiveness of CAM Therapies in Pediatric Patients Undergoing Sedation
NCT01858350
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
NCT00946660
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
NCT01052220
Marijuana Drug Discrimination and Self-Administration
NCT00943930
A Study of Ultrasonography With Elastography in Skin Neoplasms
NCT01259037
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
NCT00689819
Evaluating a Chronic Pain Treatment Program
NCT00861302
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
NCT00698737
Effects of Stress and Other Factors on Opiate Drug Choice.
NCT00684840
Computer-based Brief Intervention for Perinatal Substance Abuse
NCT00685074
The Use of Propranolol to Block Memory Reconsolidation in PTSD
NCT00611871
Prize Reinforcement for Smoking Cessation
NCT00865254
Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals.
NCT00608504
Computer-Assisted Intervention for Smoking During Pregnancy
NCT01028131
High Dose Ascorbic Acid Treatment of CMT1A
NCT00484510
Study of Intensive, Home-Based Family Therapy to Improve Illness Management in Youth With Diabetes
NCT00372814
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 18 |
| Phase 2 | 12 |
| Phase 3 | 2 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the Wayne State University pipeline
22 recruiting of 163 indexed (13% open); 115 completed (71%).
Phase mix: 13 late (III/IV) vs 30 early (I/II) (early-phase heavy).
Top condition: Hypertension (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wayne State University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Wayne State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Temple University · 163 trials · 13% recruiting
- Tufts University · 163 trials · 6% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- University of Michigan · 13% recruiting · 1,327 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Beth Israel Deaconess Medical Center · 14% recruiting · 488 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Wayne State University page
163 registered trials is a research-attention snapshot, not an endorsement of Wayne State University or any single study.
- 22 of Wayne State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Wayne State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wayne State University pipeline card: 163 registered trials from official public datasets.Report a data error.